The intake of oral semaglutides such as Wegovy or Rybelsus among adults with type 2 diabetes (T2D) was associated with a reduced risk of heart failure (HF) compared to those who took a placebo, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results